Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

20.780
-0.300-1.42%
Volume:1.39M
Turnover:29.10M
Market Cap:55.25B
PE:18.11
High:21.160
Open:21.100
Low:20.780
Close:21.080
52wk High:29.000
52wk Low:12.202
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:0.28
T/O Rate:0.26%
Dividend:0.35
Dividend Rate:1.68%
EPS(LYR):1.147
ROE:6.75%
ROA:1.32%
PB:1.04
PE(LYR):18.11
PS:1.26

Loading ...

Fosun Pharma's $1.4B Bet on Controversial Alzheimer's Drug: What's the Strategy?

Deep News
·
Yesterday

Fosun Pharma, ClavisBio Sign Five-Year Drug Collaboration Agreement; Shanghai Shares Rise 3%

MT Newswires Live
·
Dec 19

Fosun United Health Insurance Withdraws Announcement of 9 Medical Insurance Plans Covering Innovative Drugs

Deep News
·
Dec 18

FOSUN PHARMA (600196.SH) Subsidiary Signs Collaboration and Option Agreement with Clavis Bio

Stock News
·
Dec 18

Fosun Pharma Acquires Green Valley Pharma: A Ray of Hope for Alzheimer's Patients?

Deep News
·
Dec 16

HKEX Announcement Highlights | GUOXIA TECH to List Tomorrow with 1,890.73x Oversubscription; Big Three Airlines Report Over 10% YoY Passenger Traffic Growth in November

Stock News
·
Dec 15

FOSUN PHARMA (600196.SH): Supplemental New Drug Application for Serplulimab Injection Accepted

Stock News
·
Dec 12

FOSUN PHARMA (600196.SH): Ketoprofen Patch Receives Clinical Trial Approval

Stock News
·
Dec 12

Capital Securities Maintains "Buy" Rating on Fosun Pharma (02196) with Target Price of HK$26.5

Stock News
·
Dec 10

Pfizer Turns to China for Trial Weight Loss Drug. Congress Is Worried About Chinese Biotechs. -- Barrons.com

Dow Jones
·
Dec 10

FOSUN PHARMA (600196.SH): HLX22 Combined with HLX87 Injection Receives Clinical Trial Approval

Stock News
·
Dec 09

Fosun Pharma Subsidiary Yao Pharma Grants Pfizer Exclusive Global License for Oral GLP-1R Agonists

Reuters
·
Dec 09

Fosun Pharmaceutical Says Unit to Receive Upfront Payment of $150 Mln

THOMSON REUTERS
·
Dec 09

BRIEF-Fosun Pharmaceutical Says Unit Signs Licensing Agreement With Pfizer

Reuters
·
Dec 09

Fosun Pharma (600196.SH, 02196.HK) Gains Approval for Clinical Trial of FXS0887

Bulletin Express
·
Dec 03

FOSUN PHARMA (02196): Liu Yi Elected as Executive Director

Stock News
·
Dec 02

Fosun Pharma (02196.HK / 600196.SH) Releases November 2025 Monthly Return on Movements in Securities

Bulletin Express
·
Dec 02

Fosun Pharma's (600196.SH) Subsidiary Receives Clinical Trial Approval for HLX37 Injection

Stock News
·
Dec 01

Fosun Pharmaceutical's Routine Transaction Amounts to 132 Million Yuan in First Nine Months

MT Newswires Live
·
Dec 01

Fosun Pharma (02196.HK) Announces Three Continuing Connected Transactions with CQ Pharma (000950.SZ) and Fosun International (00656.HK)

Bulletin Express
·
Nov 28